1. New Modalities, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK
2. Discovery Sciences, IMED Biotech Unit, AstraZeneca, Macclesfield, UK
3. IMED Operations, AstraZeneca, Cambridge, UK
4. Surgery and Cancer, Imperial College London, London, UK
5. New Modalities, Drug Safety and Metabolism, IMED, AstraZeneca, Gothenburg, Sweden
6. Nonclinical Development, Ionis Pharmaceuticals, Inc, Carlsbad, California